Evaluating AI Performance in Systematic Literature Reviews for HEOR: A Case Study [0.03%]
人工智能在HEOR系统性文献回顾中的表现评估：案例研究
Jing Wang-Silvanto,Mansee Jajoo,He Guo et al.
Jing Wang-Silvanto et al.
Background: Systematic literature reviews (SLRs) are central to evidence generation in health economics and outcomes research, but traditional SLR workflows are labor-intensive. Artificial intelligence (AI) is increasingl...
Evaluating AI Performance in Systematic Literature Reviews for HEOR: A Case Study [0.03%]
AI在卫生经济与结果研究系统综述中的性能评估：案例研究
Jing Wang-Silvanto,Mansee Jajoo,He Guo et al.
Jing Wang-Silvanto et al.
Background: Systematic literature reviews (SLRs) are central to evidence generation in health economics and outcomes research, but traditional SLR workflows are labor-intensive. Artificial intelligence (AI) is increasingl...
Adult T-cell Leukemia/Lymphoma in Japan: Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs [0.03%]
日本成人T细胞白血病/淋巴瘤的现实世界治疗模式、卫生资源利用和成本
Charles Dharmani,Zahid Islam,Pingping Qu et al.
Charles Dharmani et al.
Background: Adult T-cell leukemia/lymphoma (ATL) is a rare and aggressive type of peripheral T-cell malignancy caused by the human T-lymphotropic virus type 1 (HTLV-1). Approximately 5 to 10 million people are infected wi...
Real-World Economic Outcomes of Patients with Localized Prostate Cancer Treated with External Beam Radiation Therapy or Radical Prostatectomy [0.03%]
根治性前列腺切除术或外照射治疗的局部前列腺癌患者的现实世界经济结局
Lawrence Karsh,Shawn Du,Jinghua He et al.
Lawrence Karsh et al.
Background: External beam radiation therapy (EBRT) and radical prostatectomy (RP) are definitive options for patients with localized or locally advanced prostate cancer (LPC). Limited evidence exists on the post-treatment...
Estimating Impact of SARS-CoV-2 Infection on Health-Related Quality of Life Among Persons Aged 8 Years and Older, August 2020-July 2022 [0.03%]
估计2020年8月～2022年7月期间8岁及以上人群感染SARS-CoV-2对健康相关生活质量的影响
Sheroi Johnson,Huong Q Nguyen,Melissa S Stockwell et al.
Sheroi Johnson et al.
Background: Severe COVID-19 results in substantial economic burden and impacts quality of life. Assessing how mild COVID-19 impacts health utilities during acute infection and long term is important to estimate the full economic impact of S...
Understanding Ehlers-Danlos Syndrome: A Claims-Based Analysis of Healthcare Cost Patterns [0.03%]
理解埃勒斯-丹洛斯综合征：基于保险理赔的医疗费用模式分析
Samson A Oyediran,Youngran Kim,Zhanna Novikov et al.
Samson A Oyediran et al.
Background: Ehlers-Danlos Syndrome (EDS) is a rare connective tissue disorder associated with substantial clinical complexity and healthcare utilization. Despite increasing recognition of EDS, little is known about its economic burden in th...
Identifying Minimum Threshold Level of Trial Crossover Rates Yielding Nonsignificant Overall Survival Benefit Associated with Cancer Treatments: A Systematic Literature Review of HTA Submissions [0.03%]
基于卫生技术评估提交的文献系统综述确定与癌症治疗方法相关的无益总体生存率的最小交叉试验阈值水平
Anandaroop Dasgupta,Ankita Kaushik,Barinder Singh et al.
Anandaroop Dasgupta et al.
Background: Crossover distortion in oncology trials occurs when control-arm patients switch to agent(s) in the experimental arm, potentially attenuating treatment effects in intention-to-treat (ITT) overall survival (OS) ...
Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios [0.03%]
司美格鲁肽2.4毫克治疗日本肥胖人群的经济效果：一种涵盖复治方案的生命经济学模型研究
Yuta Kamada,Shogo Wada,Hiroyuki Matsuda et al.
Yuta Kamada et al.
Background: Obesity is a chronic disease associated with substantial morbidity and healthcare costs. In Japan, the Optimal Use Promotion Guidelines (OUG) impose restrictions on patient eligibility for semaglutide 2.4 mg a...
Cost-Effectiveness Analysis of Annual vs Biennial Fecal Immunochemical Testing for Colorectal Cancer Screening in Japan: A Microsimulation Analysis [0.03%]
日本结直肠癌筛查的每年与每两年一次的粪便免疫化学法检测的成本效益分析：微观模拟研究
Taichi Mori,Nobuyuki Shimohata,Rei Goto
Taichi Mori
Background: The optimal screening interval for fecal immunochemical testing (FIT) in Japan remains uncertain. Objective: This study aim...
Unlocking the Value of Patient Self-Monitoring Technologies: A Multi-Country Framework to Calibrate Payer and HTA Coverage and Reimbursement Considerations with Innovation [0.03%]
基于创新的患者自我监测技术的 payer 和 hta 付款人覆盖和补偿标准多国校准框架
James K Karichu,Shafie Kamaruddin,Pinar Bilir et al.
James K Karichu et al.
Background: Patient self-monitoring (PSM) is emerging as an innovative modality for chronic disease management. While PSM technologies are established in therapeutic areas including diabetes and cardiovascular diseases, c...